These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20941745)

  • 21. Non-syndromic oligodontia with a novel mutation of PAX9.
    Suda N; Ogawa T; Kojima T; Saito C; Moriyama K
    J Dent Res; 2011 Mar; 90(3):382-6. PubMed ID: 21098475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional analysis of the human PAX9 promoter.
    Almeida CV; Andrade SC; Saito CP; Ramenzoni LL; Line SR
    J Appl Oral Sci; 2010; 18(5):482-6. PubMed ID: 21085804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin.
    Takano Y; Yamauchi K; Hiramatsu N; Kasai A; Hayakawa K; Yokouchi M; Yao J; Kitamura M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1573-82. PubMed ID: 17244893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exclusion of coding region mutations in MSX1, PAX9 and AXIN2 in eight patients with severe oligodontia phenotype.
    Gerits A; Nieminen P; De Muynck S; Carels C
    Orthod Craniofac Res; 2006 Aug; 9(3):129-36. PubMed ID: 16918677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of involucrin gene expression by retinoic acid and glucocorticoids.
    Monzon RI; LaPres JJ; Hudson LG
    Cell Growth Differ; 1996 Dec; 7(12):1751-9. PubMed ID: 8959344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic mechanisms of tooth agenesis linked to paired domain mutations in human PAX9.
    Wang Y; Groppe JC; Wu J; Ogawa T; Mues G; D'Souza RN; Kapadia H
    Hum Mol Genet; 2009 Aug; 18(15):2863-74. PubMed ID: 19429910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revision of "A 223-kb de novo deletion of PAX9 in a patient with oligodontia".
    Haldeman-Englert CR; Biser A; Zackai EH; Ming JE
    J Craniofac Surg; 2012 Mar; 23(2):e149-51. PubMed ID: 22446453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel missense mutations in PAX9 causing oligodontia.
    Liang J; Song G; Li Q; Bian Z
    Arch Oral Biol; 2012 Jun; 57(6):784-9. PubMed ID: 22277187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and functional analysis of two novel PAX9 mutations.
    Wang Y; Wu H; Wu J; Zhao H; Zhang X; Mues G; D'Souza RN; Feng H; Kapadia H
    Cells Tissues Organs; 2009; 189(1-4):80-7. PubMed ID: 18701815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel g.-1258G>A mutation in a conserved putative regulatory element of PAX9 is associated with autosomal dominant molar hypodontia.
    Mendoza-Fandino GA; Gee JM; Ben-Dor S; Gonzalez-Quevedo C; Lee K; Kobayashi Y; Hartiala J; Myers RM; Leal SM; Allayee H; Patel PI
    Clin Genet; 2011 Sep; 80(3):265-72. PubMed ID: 21443745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAX9 and MSX1 transcription factor genes in non-syndromic dental agenesis.
    Paixão-Côrtes VR; Braga T; Salzano FM; Mundstock K; Mundstock CA; Bortolini MC
    Arch Oral Biol; 2011 Apr; 56(4):337-44. PubMed ID: 21111400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb.
    Lee JC; Sharma M; Lee YH; Lee NH; Kim SY; Yun JS; Nam SY; Hwang PH; Jhee EC; Yi HK
    Cell Biochem Funct; 2008 Dec; 26(8):892-9. PubMed ID: 18979497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel polymorphic variants within the paired box of the PAX9 gene are associated with selective tooth agenesis.
    Kobielak A; Kobielak K; Wiśniewski AS; Mostowska A; Biedziak B; Trzeciak WH
    Folia Histochem Cytobiol; 2001; 39(2):111-2. PubMed ID: 11374781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis.
    Bhol CS; Patil S; Sahu BB; Patra SK; Bhutia SK
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188561. PubMed ID: 33965511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone.
    Staples KJ; Bergmann MW; Barnes PJ; Newton R
    Immunology; 2003 Aug; 109(4):527-35. PubMed ID: 12871219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A missense mutation in PAX9 in a family with distinct phenotype of oligodontia.
    Lammi L; Halonen K; Pirinen S; Thesleff I; Arte S; Nieminen P
    Eur J Hum Genet; 2003 Nov; 11(11):866-71. PubMed ID: 14571272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural selection and molecular evolution in primate PAX9 gene, a major determinant of tooth development.
    Pereira TV; Salzano FM; Mostowska A; Trzeciak WH; Ruiz-Linares A; Chies JA; Saavedra C; Nagamachi C; Hurtado AM; Hill K; Castro-de-Guerra D; Silva-Júnior WA; Bortolini MC
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5676-81. PubMed ID: 16585527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-EDAR Agonist Antibody Therapy Resolves Palate Defects in Pax9
    Jia S; Zhou J; Wee Y; Mikkola ML; Schneider P; D'Souza RN
    J Dent Res; 2017 Oct; 96(11):1282-1289. PubMed ID: 28813171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic Acid Modulates PTGDR Promoter Activity.
    García-Sánchez A; Marcos-Vadillo E; Sanz C; Hernández-Hernández L; Cerutti-Müller G; Marqués-García F; Lorente F; Isidoro-García M; Dávila I
    J Investig Allergol Clin Immunol; 2016; 26(4):249-55. PubMed ID: 27373883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAX9 in Cancer Development.
    Chen X; Li Y; Paiboonrungruang C; Li Y; Peters H; Kist R; Xiong Z
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.